Seto M - Search Results

1

Liao JK, Seto M, Noma K. Liao JK, et al. Among authors: seto m. J Cardiovasc Pharmacol. 2007 Jul;50(1):17-24. doi: 10.1097/FJC.0b013e318070d1bd. J Cardiovasc Pharmacol. 2007. PMID: 17666911 Free PMC article. Review.

2

Increased leukocyte ROCK activity in patients after acute ischemic stroke.

Feske SK, Sorond FA, Henderson GV, Seto M, Hitomi A, Kawasaki K, Sasaki Y, Asano T, Liao JK. Feske SK, et al. Among authors: seto m. Brain Res. 2009 Feb 27;1257:89-93. doi: 10.1016/j.brainres.2008.12.045. Epub 2008 Dec 25. Brain Res. 2009. PMID: 19133241 Free PMC article.

3

Inhibition of Rho kinase (ROCK) leads to increased cerebral blood flow and stroke protection.

Rikitake Y, Kim HH, Huang Z, Seto M, Yano K, Asano T, Moskowitz MA, Liao JK. Rikitake Y, et al. Among authors: seto m. Stroke. 2005 Oct;36(10):2251-7. doi: 10.1161/01.STR.0000181077.84981.11. Epub 2005 Sep 1. Stroke. 2005. PMID: 16141422 Free PMC article.

4

Prostacyclin does not inhibit rho-kinase: an implication for the treatment of pulmonary hypertension.

Abe K, Morikawa K, Hizume T, Uwatoku T, Oi K, Seto M, Ikegaki I, Asano T, Kaibuchi K, Shimokawa H. Abe K, et al. Among authors: seto m. J Cardiovasc Pharmacol. 2005 Feb;45(2):120-4. doi: 10.1097/01.fjc.0000151898.65260.6a. J Cardiovasc Pharmacol. 2005. PMID: 15654260

5

Inhibition of protein kinase C-mediated contraction by Rho kinase inhibitor fasudil in rabbit aorta.

Shimomura E, Shiraishi M, Iwanaga T, Seto M, Sasaki Y, Ikeda M, Ito K. Shimomura E, et al. Among authors: seto m. Naunyn Schmiedebergs Arch Pharmacol. 2004 Nov;370(5):414-22. doi: 10.1007/s00210-004-0975-9. Epub 2004 Oct 1. Naunyn Schmiedebergs Arch Pharmacol. 2004. PMID: 15459803

6

Demonstration of elevation and localization of Rho-kinase activity in the brain of a rat model of cerebral infarction.

Yano K, Kawasaki K, Hattori T, Tawara S, Toshima Y, Ikegaki I, Sasaki Y, Satoh S, Asano T, Seto M. Yano K, et al. Among authors: seto m. Eur J Pharmacol. 2008 Oct 10;594(1-3):77-83. doi: 10.1016/j.ejphar.2008.07.045. Epub 2008 Jul 31. Eur J Pharmacol. 2008. PMID: 18703046

7

Rho-kinase-mediated pathway induces enhanced myosin light chain phosphorylations in a swine model of coronary artery spasm.

Shimokawa H, Seto M, Katsumata N, Amano M, Kozai T, Yamawaki T, Kuwata K, Kandabashi T, Egashira K, Ikegaki I, Asano T, Kaibuchi K, Takeshita A. Shimokawa H, et al. Among authors: seto m. Cardiovasc Res. 1999 Sep;43(4):1029-39. doi: 10.1016/s0008-6363(99)00144-3. Cardiovasc Res. 1999. PMID: 10615430

8

[Rho-kinase inhibitors].

Seto M, Asano T. Seto M, et al. Nihon Yakurigaku Zasshi. 2011 Sep;138(3):112-6. doi: 10.1254/fpj.138.112. Nihon Yakurigaku Zasshi. 2011. PMID: 21908938 Review. Japanese. No abstract available.

9

[Development of Rho kinase inhibitors for pulmonary arterial hypertension].

Seto M. Seto M. Nihon Yakurigaku Zasshi. 2012 Jun;139(6):251-5. doi: 10.1254/fpj.139.251. Nihon Yakurigaku Zasshi. 2012. PMID: 22728987 Review. Japanese. No abstract available.

10

Essential role of rho kinase in the Ca2+ sensitization of prostaglandin F(2alpha)-induced contraction of rabbit aortae.

Ito K, Shimomura E, Iwanaga T, Shiraishi M, Shindo K, Nakamura J, Nagumo H, Seto M, Sasaki Y, Takuwa Y. Ito K, et al. Among authors: seto m. J Physiol. 2003 Feb 1;546(Pt 3):823-36. doi: 10.1113/jphysiol.2002.030775. J Physiol. 2003. PMID: 12563007 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

945 results

Search Page

Filters